Contravisory Investment Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,062
Closed -$515K 427
2023
Q3
$515K Buy
15,062
+30
+0.2% +$1.14K 0.15% 92
2023
Q2
$602K Buy
+15,032
New +$598K 0.16% 81
2020
Q1
Sell
-6,441
Closed -$364K 325
2019
Q4
$364K Buy
6,441
+77
+1% +$4.29K 0.13% 101
2019
Q3
$339K Sell
6,364
-62
-1% -$3.33K 0.13% 99
2019
Q2
$375K Buy
+6,426
New +$345K 0.15% 83
2016
Q4
Sell
-3,108
Closed -$185K 330
2016
Q3
$185K Buy
3,108
+254
+9% +$15.6K 0.06% 62
2016
Q2
$177K Hold
2,854
0.05% 65
2016
Q1
$176K Buy
+2,854
New +$168K 0.05% 64

Other funds holding XRAY

Contravisory Investment Management's XRAY Position: Q4 2023 in Review

Contravisory Investment Management sold out of Dentsply Sirona (XRAY) in Q4 2023, closing a stake of 15,062 shares — an estimated $515K sold.

Contravisory Investment Management first reported a position in XRAY in Q1 2016 and held it in 8 quarters. The position peaked at $602K in Q2 2023. 416 funds tracked by Wall St. Rank hold XRAY as of Q4 2023.

  • Contravisory Investment Management reported no remaining Dentsply Sirona position as of Q4 2023 after selling out during the quarter.
  • Contravisory Investment Management sold 15,062 Dentsply Sirona shares in Q4 2023, an estimated $515K.
  • Contravisory Investment Management first reported a position in Dentsply Sirona in Q1 2016 and held it in 8 quarters.
  • Contravisory Investment Management's Dentsply Sirona position peaked at $602K in Q2 2023.
  • 416 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2023.

Based on Contravisory Investment Management's 13F filing for Q4 2023, filed 11 Jan 2024.